Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03616483

The Indiana Myeloma Registry

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Plasma Cell Dyscrasias Blood Protein Disorders Cardiovascular Diseases Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhagic Disorders Hemostatic Disorders Hypergammaglobulinemia Immune System Diseases Immunoproliferative Disorders Lymphoproliferative Disorders Monoclonal Gammopathy of Undetermined Significance Multiple Myeloma Neoplasms Neoplasms by Histologic Type Neoplasms, Plasma Cell Paraproteinemias Plasmacytoma Precancerous Conditions Smoldering Multiple Myeloma Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female patients ≥ 18 years of age at the time of informed consent
  • Has been diagnosed with or is suspected to have one of the following:
  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Smoldering Multiple Myeloma
  • Multiple Myeloma
  • Bony or Soft Tissue Plasmacytoma
  • Primary Amyloidosis

Exclusion criteria

< 18 years of age

Have not been diagnosed with one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Treatment and study plan

This is a non-interventional trial

Other

This is a non-interventional trial

Primary outcomes

  1. Create a repository

    Time frame: 5 years

    The primary objective of this study is to provide a mechanism to store comprehensive clinical, genomic, demographic, social, environmental and quality of life data from subjects with plasma cell dyscrasias

Secondary outcomes

  1. Data collection

    Time frame: 5 years

    To collect data related to clonal evolution, tumor microenvironment, clinical outcomes, adverse events, environmental factors and quality of life that will provide the foundation to create hypotheses for future confirmatory studies.

Study contacts

Contact information is provided by the study sponsor or research team.

Attaya Suvannasankha, MD

CONTACT

[email protected]

317-274-0843

Nisha George, MD

CONTACT

[email protected]

(317) 274-6635

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Official study title

Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry

Important dates

Study start
2018
Primary completion
2028
Study completion
2028
First posted
Aug 6, 2018
Registry last updated
Nov 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.